Clinical Trials Logo

Economic Burden clinical trials

View clinical trials related to Economic Burden.

Filter by:
  • None
  • Page 1

NCT ID: NCT06068309 Recruiting - Hypertension Clinical Trials

Efficacy of CareAide® App in Improving Adherence in Adults With Chronic Diseases

CAREAide
Start date: July 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to study the impact of a medication adherence app, CareAide, in adult population diagnosed with chronic diseases in Malaysian population. The main question[s] it aims to answer are: 1. Can CareAide make people take their medications better and improve their health? 2. Can CareAide improve the health of people with chronic diseases? 3. Does using CareAide make people's lives better? 4. Can CareAide save money when managing chronic diseases? 5. How do people feel about using CareAide? Researchers will ask the participants to use the CareAide app for 6 months and compare the group that used the app with the other group which just received the usual treatment. Researchers will check if they do better with their medications, feel healthier, have a better life, and spend less money. They will check this twice, once after 3 months and again after 6 months. adherence, clinical outcomes, quality of life and economic associated with the app with two follow ups at 3 month intervals.

NCT ID: NCT04482205 Completed - Economic Burden Clinical Trials

Covid -19 Pandemic: Economic Burden on Patients Operated for Traumatic Close Fractures

Start date: March 16, 2020
Phase:
Study type: Observational

Covid-19 has adversely impacted the health care organizations by over burdening with Covid patients and suspending the elective surgeries and clinics A single center retrospective study was conducted to quantify losses due to postponement of elective surgeries and extra cost for procurement of PPEs. The secondary objective was to see the effect of Covid -19 on the total costs of inpatient care during Covid era.

NCT ID: NCT02592265 Completed - Multiple Sclerosis Clinical Trials

Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden

ECOPASEP
Start date: October 2012
Phase: N/A
Study type: Observational

The objective of this study is to measure economic burden of Multiple Sclerosis (MS) from a new point of view that includes consequences of disability on Quality Of Life (QOL), social participation and capabilities of patients and caregivers. To the investigators' knowledge, there is currently no data including intangible costs related to caregivers and calculating the overall economic cost of Multiple Sclerosis, particularly, in France.